NIH is utilizing a multi-faceted approach to strengthen policies across the life cycle of a clinical trial, from development of the funding opportunity, to the information collected in a grant application or contract proposal, peer review of the application/proposal, and through to monitoring of the award. These policies address challenges and shortcomings in the design, efficiency, and timely reporting of clinical trials. We have known for years that many NIH-funded trials are completed, yet their main results are either never made public or made public in a timely manner. Addressing these challenges will ensure the highest likelihood of translating research results into knowledge that will improve human health.
Describe the research methods. The methods section of a clinical paper provides a comprehensive explanation of how the researchers collected and analyzed the data. For every method used, a clinical paper needs to justify why this approach was the most appropriate for the purposes of the study . The methods section should be sufficiently detailed so that another researcher could precisely replicate the study. If the study used survey instruments or assessment tools, the paper should describe how these tools were developed, as well as provide a brief quantitative overview of their validity and reliability. When submitting to a scholarly journal, be sure to include the complete detail on all instruments used.